United Therapeutics (UTHR) Misses Q2 EPS, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall St on pace for higher open as oil pulls back ahead of Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| United Therapeutics Corp (NASDAQ: UTHR) | Delayed: 585.98 -6.86 (1.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $592.84 | 52 Week High | $164.04 | |||
| Open | $587.10 | 52 Week Low | $97.52 | |||
| Day High | $591.05 | P/E | 107.13 | |||
| Day Low | $582.67 | EPS | $5.47 | |||
| Volume | 29,909 | |||||
